Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.

Houdu, Benjamin; Lasnon, Charline; Licaj, Idlir; Thomas, Guy; Do, Pascal; Guizard, Anne-Valerie; Desmonts, Cédric; Aide, Nicolas

Houdu, Benjamin; Lasnon, Charline; Licaj, Idlir; Thomas, Guy; Do, Pascal; Guizard, Anne-Valerie; Desmonts, Cédric; Aide, Nicolas.

Afiliação

Houdu B; Nuclear Medicine Department, University Hospital, Caen, France.
Lasnon C; Nuclear Medicine Department, François Baclesse Cancer Centre, Caen, France.
Licaj I; INSERM ANTICIPE, Normandie University, Caen, France.
Thomas G; Clinical Research Department, François Baclesse Cancer Centre, Caen, France.
Do P; Medical Informatics Department, François Baclesse Cancer Centre, Caen, France.
Guizard AV; Lung Cancer Unit, François Baclesse Cancer Centre, Caen, France.
Desmonts C; Regional Cancer Registry, François Baclesse Cancer Centre, Caen, France.
Aide N; Nuclear Medicine Department, University Hospital, Caen, France.

Eur J Nucl Med Mol Imaging ; 46(2): 533-534, 2019 02.

Article em En | MEDLINE | ID: mdl-30535744

ABSTRACT

ABSTRACT

An error occurred in the labelling of Fig. 3, where math symbols for SUV thresholds were inverted in panel b when the EARL threshold was applied to the PSF dataset and vice versa. This figure should read as follows Fig. 3 Prognostic value of tumour SUVmax.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google